[Kidney and hypertension--evidence based medicine].
Nakao
Naoyuki
N
Senou
Hachiro
H
Kasuga
Hirotake
H
Toriyama
Takanobu
T
Kawahara
Hirohisa
H
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D019808:Losartan / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D019808:Losartan